Company intelligence / Profile preview

Biosynth

Staad, St. Gallen, Switzerlandbiosynth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biosynth operates globally as a leading supplier of critical raw materials—including complex chemicals, peptides, enzymes, antibodies—and offers custom synthesis and end-to-end CDMO services. The company supports pharmaceutical development from early discovery through GMP manufacturing. It boasts an extensive catalog with over half a million products and specializes in solving complex chemistry challenges at all scales. No clinical results are reported since the company does not develop its own therapeutics.

Modalities: Small moleculesPeptidesBiologics
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Biosynth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosynth.

Explore the full profile